Erloshil 150 mg Tablets image 1
01 / 03

Genuine Medicines

Tracked Shipping

Plain Packaging

Order Metadata
ReferenceGH·ERLOSHIL
AvailabilityIn stock
SourceIndia
Delivery5–10 business days to your country
GH·ERLOSHILAnti-Cancer / Oncology Medicines

Erloshil 150 mg Tablets

Erlotinib is a prescription anticancer medicine used to treat certain types of lung cancer and pancreatic cancer. It works by blocking a protein called epidermal growth factor receptor (EGFR), which helps cancer cells grow and multiply. By blocking this protein, Erlotinib slows down cancer growth and may help prevent the spread of cancer cells. It is used under the supervision of an oncologist.

Order This Product

Send us a message on WhatsApp with this product name — we'll come back with the price and delivery options for your country.

Description

Erlotinib is an anticancer medicine belonging to the tyrosine kinase inhibitor group, primarily used to treat certain types of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by blocking the epidermal growth factor receptor (EGFR), a protein involved in controlling cell growth and division. In cancers with specific EGFR mutations, this action helps slow down or stop the growth and multiplication of cancer cells. It may be prescribed alone for certain lung cancers or in combination with Gemcitabine for advanced pancreatic cancer. The medicine is usually taken orally once daily on an empty stomach, at least one hour before or two hours after food, as directed by the oncologist. The dosage depends on the type of cancer, treatment response, and patient's overall health. Common side effects include skin rash, diarrhea, nausea, loss of appetite, mouth sores, fatigue, and dry skin. Serious side effects may include lung inflammation, liver problems, kidney problems, gastrointestinal bleeding, and severe dehydration due to persistent diarrhea. Patients should avoid smoking during treatment because smoking can reduce the effectiveness of Erlotinib. It may interact with medicines such as rifampicin, certain antifungal drugs, antacids, proton pump inhibitors, and other medicines that affect liver enzymes or stomach acidity. Regular medical monitoring is necessary to assess treatment effectiveness and detect possible side effects. Patients should seek immediate medical attention if they experience severe breathing difficulties, persistent diarrhea, severe abdominal pain, or yellowing of the skin or eyes. Erlotinib should only be used under medical supervision and should not be stopped or adjusted without consulting the treating doctor.

Specifications

Composition
Erlotinib
Strength
150 mg
Treatment
Non-Small Cell Lung Cancer (NSCLC) and Pancreatic Cancer
Packaging Type
Bottle
Packaging Size
10 Tablets

How this product reaches you

  1. 1Global Healthcare sources this product from a manufacturer in India. The manufacturer name and country are part of the order record.
  2. 2It is shipped from India to your address. Carrier and delivery options depend on your country and order size.
  3. 3Your country's import rules apply — we help you understand them on chat.

Similar Products